Acarbose and Norvasc drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Acarbose (acarbose) and Norvasc (amlodipine besylate). Common drug interactions include fatigue among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Acarbose and Norvasc. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.
What is Acarbose?
Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.
What is Norvasc?
Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.
71 people who take Acarbose and Norvasc together, and have interactions are studied.

What are the common drug interactions of Acarbose and Norvasc, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Flatulence (flatus expelled through the anus)
- Hepatic enzyme increased
- Hyperglycaemia (high blood sugar)
- Hypersensitivity
- Pneumonia
- Pruritus (severe itching of the skin)
- Seasonal allergy (allergic condition due to certain season)
- Sneezing
- Tremor (trembling or shaking movements in one or more parts of your body)
male:
- Renal failure (kidney dysfunction)
- Anxiety
- Cardiomyopathy (weakening of the heart muscle)
- Coronary artery stenosis (narrowing of coronary artery)
- Depression
- Haematocrit decreased
- Haemoglobin decreased
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
- Pneumonia
What are the common drug interactions of Acarbose and Norvasc, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anxiety
- Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
- Depression
- Dysuria (painful or difficult urination)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Gastrointestinal perforation (hole in the digestive tract)
- Immune system disorder
- Nephrolithiasis (calculi in the kidneys)
- Pancreatitis (inflammation of pancreas)
- Pneumonia
40-49:
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
50-59:
- Pneumonia
- Renal failure (kidney dysfunction)
- Cardiac failure congestive
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Pericardial effusion (fluid around the heart)
- Presyncope
- Renal failure chronic (long lasting kidney dysfunction)
- Asthenia (weakness)
- Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
60+:
- Blood glucose increased
- Pain
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Flatulence (flatus expelled through the anus)
- Hepatic enzyme increased
- Hyperglycaemia (high blood sugar)
- Hypersensitivity
- Hypotension (abnormally low blood pressure)
- Pruritus (severe itching of the skin)
What are the existing conditions these people have? *
- Type 2 Diabetes: 13 people, 18.31%
- Cardiac Disorder: 10 people, 14.08%
- High Blood Cholesterol: 5 people, 7.04%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 7.04%
* Approximation only. Some reports may have incomplete information.
Do you take Acarbose and Norvasc?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Acarbose and Norvasc:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Acarbose:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Norvasc:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acarbose and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Norvasc and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on acarbose and amlodipine besylate (the active ingredients of Acarbose and Norvasc, respectively), and Acarbose and Norvasc (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tacrolimus cause Thrombocytosis? - 4 seconds ago
- Could Fosfomycin Tromethamine cause Overdose? - 11 seconds ago
- Could Cefadroxil cause Taste - Impaired? - 12 seconds ago
- Could Diclofenac cause Electrolyte Imbalance? - 16 seconds ago
- Could Botox cause Marasmus? - 19 seconds ago
- Could Ramipril cause Temperature Intolerance? - 22 seconds ago
- Could Fanapt cause Rashes? - 26 seconds ago
- Muscle Aches and Gastroesophageal Reflux Disease - 26 seconds ago
- Drug interactions of Dupixent and Chantix - 26 seconds ago
- Could Rifinah cause Stools - Watery? - 28 seconds ago